Af­ter snatch­ing up Shire's can­cer unit, French phar­ma gi­ant Servi­er to ex­pand US pres­ence with Kendall Square in­no­va­tion of­fice

Servi­er, the French phar­ma gi­ant that just ac­quired Shire’s on­col­o­gy unit for $2.4 bil­lion, is putting a US in­no­va­tion out­post in Kendall Square. The new unit will be called Servi­er BioIn­no­va­tion, and it’s just re­cruit­ed two ex­ec­u­tives to head it up — like­ly hunters for part­ner­ships and tech that will ad­vance Servi­er’s pipeline.

This marks the sec­ond French phar­ma gi­ant to an­nounce a Kendall Square out­post in the past 24 hours. Just yes­ter­day, Ipsen an­nounced it was mov­ing its US head­quar­ters from New Jer­sey to Boston.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER